{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:32:43Z","timestamp":1791898363123,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA22125"],"award-info":[{"award-number":["CA22125"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.esmogo.2026.100409","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:33:48Z","timestamp":1789468428000},"page":"100409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Patterns of presentation and diagnostic delays in biliary tract cancers: a real-world European study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8852-0628","authenticated-orcid":false,"given":"A.","family":"Martirena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-6210","authenticated-orcid":false,"given":"L.","family":"Cavka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-6122","authenticated-orcid":false,"given":"A.","family":"Lamarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.esmogo.2026.100409_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.esmogo.2026.100409_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12957-024-03596-y","article-title":"Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma","volume":"22","author":"Sarkhampee","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100409_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejso.2020.01.028","article-title":"Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives","volume":"46","author":"Machairas","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.esmogo.2026.100409_bib4","article-title":"Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe","volume":"50","author":"Turpin","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"10272","key":"10.1016\/j.esmogo.2026.100409_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.esmogo.2026.100409_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005720","article-title":"A case\u2013control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer","volume":"4","author":"Keane","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.esmogo.2026.100409_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12957-024-03573-5","article-title":"Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region","volume":"22","author":"Thanasukarn","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.esmogo.2026.100409_bib9","article-title":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.esmogo.2026.100409_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.esmogo.2026.100409_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/flgastro-2022-102172","article-title":"Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: can we be more proactive?","volume":"14","author":"Gleeson","year":"2023","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.esmogo.2026.100409_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2022.05.036","article-title":"Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer","volume":"77","author":"H\u00f8gdall","year":"2022","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.esmogo.2026.100409_bib13","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/bjc.2013.569","article-title":"Emergency presentation of cancer and short-term mortality","volume":"109","author":"McPhail","year":"2013","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1016\/j.esmogo.2026.100409_bib14","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3748\/wjg.v29.i24.3825","article-title":"Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017","volume":"29","author":"Zalin-Miller","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.esmogo.2026.100409_bib15","article-title":"New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100409_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/MEG.0000000000002947","article-title":"Global trends and disparities in gallbladder and biliary tract cancers: insights from the Global Burden of Disease study 2021","volume":"37","author":"Zhao","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.esmogo.2026.100409_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101936","article-title":"Current standards and future perspectives in adjuvant treatment for biliary tract cancers","volume":"84","author":"Lamarca","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.esmogo.2026.100409_bib18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/liv.14856","article-title":"Nationwide treatment and outcomes of perihilar cholangiocarcinoma","volume":"41","author":"van Keulen","year":"2021","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100409_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100409_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2026.100409_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"26","key":"10.1016\/j.esmogo.2026.100409_bib22","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.3748\/wjg.v22.i26.6065","article-title":"Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy","volume":"22","author":"Lamarca","year":"2016","journal-title":"World J Gastroenterol"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819826001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819826001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:33:37Z","timestamp":1790112817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819826001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"alternative-id":["S2949819826001093"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2026.100409","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of presentation and diagnostic delays in biliary tract cancers: a real-world European study","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2026.100409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100409"}}